Jeffrey Meyer: key facts
- Kind of voice
- Academic
- Role
- neurochemist at the University of Toronto
- Quoted on
- Long Covid
- Press citations held
- 1
- Most recently quoted
- 12 Aug 2026
“The marker of nerve damage used in the study could potentially be used to diagnose long COVID, Jeffrey Meyer, a neurochemist at the University of Toronto, told ScienceAlert. Some people with long COVID might respond to "treatments which either increase the density of dopamine nerve terminals or improve the release of dopamine by the remaining dopamine nerve terminals", said Meyer.”
Where Jeffrey Meyer has been quoted
- Long COVID Patients Have 18% Fewer Dopamine Nerve Endings, Brain Scans Revealsciencealert.com · 12 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.